Renalytix AI

Renalytix AI specializes in developing artificial intelligence-enabled diagnostic solutions for kidney diseases, a prevalent and costly chronic condition worldwide. The company offers the KidneyIntelX platform, which utilizes an AI-driven algorithm to integrate various data inputs, such as validated blood-based biomarkers, genetic information, and personalized patient data from electronic health records, to generate unique patient risk scores. Renalytix AI collaborates with several institutions, including Mount Sinai Health System and Joslin Diabetes Center, to advance the commercialization of products aimed at diagnosing and predicting kidney disease. Its technology enhances kidney disease risk assessment, clinical care, and patient stratification for drug trials, ultimately aiming to improve the predictive capabilities and clinical utility of kidney disease diagnostics. Founded in 2018, Renalytix AI is headquartered in Cardiff, United Kingdom.